YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise primarily engaged in the development, manufacturing, and distribution of medicinal products. Operating within the People's Republic of China, its therapeutic expertise spans antiviral treatments, solutions for endocrine and metabolic disorders, and cardiovascular health. In addition to finished pharmaceuticals, the company produces and markets active pharmaceutical ingredients (APIs) and dedicates resources to the research and development of medical devices, novel drugs, and biotechnology.